Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
New HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib, and nilotinib in human plasma.
De Francia S, D'Avolio A, De Martino F, Pirro E, Baietto L, Siccardi M, Simiele M, Racca S, Saglio G, Di Carlo F, Di Perri G. De Francia S, et al. Among authors: de martino f. J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Jun 15;877(18-19):1721-6. doi: 10.1016/j.jchromb.2009.04.028. Epub 2009 Apr 24. J Chromatogr B Analyt Technol Biomed Life Sci. 2009. PMID: 19428316
HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC).
D'Avolio A, Simiele M, De Francia S, Ariaudo A, Baietto L, Cusato J, Fava C, Saglio G, Di Carlo F, Di Perri G. D'Avolio A, et al. Among authors: de francia s. J Pharm Biomed Anal. 2012 Feb 5;59:109-16. doi: 10.1016/j.jpba.2011.10.003. Epub 2011 Oct 14. J Pharm Biomed Anal. 2012. PMID: 22036594 Free article.
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane.
D'Avolio A, De Francia S, Basile V, Cusato J, De Martino F, Pirro E, Piccione F, Ardito A, Zaggia B, Volante M, Di Perri G, Terzolo M. D'Avolio A, et al. Among authors: de francia s, de martino f. Pharmacogenet Genomics. 2013 Jun;23(6):293-300. doi: 10.1097/FPC.0b013e3283606cb2. Pharmacogenet Genomics. 2013. PMID: 23524664 Free article.
Role of pharmacogenetics on deferasirox AUC and efficacy.
Cusato J, Allegra S, De Francia S, Massano D, Piga A, D'Avolio A. Cusato J, et al. Among authors: de francia s. Pharmacogenomics. 2016 Apr;17(6):561-72. doi: 10.2217/pgs-2015-0001. Epub 2016 Apr 4. Pharmacogenomics. 2016. PMID: 27043265
Deferasirox AUC efficacy cutoff and role of pharmacogenetics.
Allegra S, Cusato J, De Francia S, Massano D, Piga A, D'Avolio A. Allegra S, et al. Among authors: de francia s. Eur J Clin Pharmacol. 2016 Sep;72(9):1155-7. doi: 10.1007/s00228-016-2070-9. Epub 2016 May 18. Eur J Clin Pharmacol. 2016. PMID: 27193993 No abstract available.
64 results